[1]
H.-D. Allescher, R. Burgell, P. Malfertheiner, and F. Mearin, “Multi-target Treatment for Irritable Bowel Syndrome with STW 5: Pharmacological Modes of Action”, JGLD, vol. 29, no. 2, pp. 227-233, Jun. 2020.